
CRH Medical Corporation CRHM
Land |
|
IPO-Jahr |
2015 |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
71.5 M |
Marktkapitalisierung |
$ 282 M |
EBITDA (LTM) |
$ -6.25 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 68.06 | 0.27 % | $ 13.6 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 129.02 | 1.74 % | $ 7.38 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 66.67 | -0.27 % | $ 40.4 B | NYSE | ||
|
Intuitive Surgical
ISRG
|
$ 416.46 | 1.31 % | $ 149 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 144.87 | 1.87 % | $ 3.57 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 114.48 | 0.73 % | $ 3.66 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.0 | - | $ 185 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 92.49 | 0.58 % | $ 2.09 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Merit Medical Systems
MMSI
|
$ 67.16 | 0.95 % | $ 3.97 B | Nasdaq Global Select Market,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Microbot Medical
MBOT
|
$ 1.85 | 3.65 % | $ 84.7 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Milestone Scientific
MLSS
|
$ 0.36 | 1.94 % | $ 29.5 M | NYSE American | ||
|
electroCore
ECOR
|
$ 9.92 | -3.22 % | $ 84.2 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 25.05 | 1.83 % | $ 4.21 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 77.62 | -0.74 % | $ 3.66 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STERIS plc
STE
|
$ 207.0 | -0.27 % | $ 20.3 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 28.82 | 1.59 % | $ 1.43 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.91 | -2.73 % | $ 184 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 130.98 | 0.38 % | $ 5.84 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 329.62 | 0.24 % | $ 23.8 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 69.83 | 2.93 % | $ 226 M | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 25.92 | 6.36 % | $ 1.75 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.22 | 1.24 % | $ 2.04 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -1.23 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 62.48 | 0.45 % | $ 205 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 26.87 | 2.94 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.87 | 1.63 % | $ 170 M | NYSE American | ||
|
Baxter International
BAX
|
$ 21.08 | 1.05 % | $ 10.8 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 194.3 | -0.25 % | $ 28.4 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 28.57 | -0.78 % | $ 1.36 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.02 | -0.99 % | $ 267 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.13 | 0.25 % | $ 496 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 146.78 | 0.37 % | $ 42.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.34 | -0.15 % | $ 35.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.18 | -0.12 % | $ 307 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 133.62 | 2.32 % | $ 7.51 M | Nasdaq Global Select Market,SPB |